Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.103x

Based on the latest financial reports, Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a cash flow conversion efficiency ratio of 0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥670.83 Million ≈ $98.16 Million USD) by net assets (CN¥6.50 Billion ≈ $950.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Allist Pharmaceuticals Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Shanghai Allist Pharmaceuticals Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688578 total liabilities for a breakdown of total debt and financial obligations.

Shanghai Allist Pharmaceuticals Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Allist Pharmaceuticals Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ESAB Corp NYSE:ESAB	0.038x
Urban Outfitters Inc NASDAQ:URBN	0.023x
Southwest Gas Holdings Inc NYSE:SWX	0.014x
Paycom Software, Inc. NYSE:PAYC	0.113x
ViaSat Inc NASDAQ:VSAT	0.157x
QUBE Holdings Ltd AU:QUB	0.081x
Jiangsu Yoke Technology Co Ltd SHE:002409	0.062x
Zhuzhou CRRC Times Electric Co Ltd SHG:688187	0.069x

Annual Cash Flow Conversion Efficiency for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 688578 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.28 Billion ≈ $773.04 Million	CN¥1.57 Billion ≈ $229.16 Million	0.296x	+74.98%
2023-12-31	CN¥3.98 Billion ≈ $582.73 Million	CN¥674.65 Million ≈ $98.72 Million	0.169x	+489.25%
2022-12-31	CN¥3.19 Billion ≈ $466.37 Million	CN¥91.63 Million ≈ $13.41 Million	0.029x	+191.84%
2021-12-31	CN¥2.97 Billion ≈ $435.08 Million	CN¥29.29 Million ≈ $4.29 Million	0.010x	+114.41%
2020-12-31	CN¥2.88 Billion ≈ $421.15 Million	CN¥-196.75 Million ≈ $-28.79 Million	-0.068x	+68.78%
2019-12-31	CN¥1.18 Billion ≈ $173.31 Million	CN¥-259.37 Million ≈ $-37.95 Million	-0.219x	+84.00%
2018-12-31	CN¥71.04 Million ≈ $10.39 Million	CN¥-97.25 Million ≈ $-14.23 Million	-1.369x	-5261.91%
2017-12-31	CN¥381.26 Million ≈ $55.79 Million	CN¥10.11 Million ≈ $1.48 Million	0.027x	--

About Shanghai Allist Pharmaceuticals Co. Ltd. A

SHG:688578 China Biotechnology

Market Cap

$6.29 Billion

CN¥42.99 Billion CNY

Market Cap Rank

#3103 Global

#439 in China

Share Price

CN¥95.53

Change (1 day)

+3.16%

52-Week Range

CN¥83.40 - CN¥118.30

All Time High

CN¥118.30